Notify me when Whitefort Capital Management, LP files a new Schedule 13D/G report.
⭐ Subscribe ⭐| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| OABI | OmniAb, Inc. | Common Stock, $0.0001 par value per share | 9.9% | $22,757,853 | +$6,373,619 | 14,223,658 | +39% | Whitefort Capital Management, LP | 30 Sep 2025 |
| VATE | INNOVATE Corp. | Common Stock, par value $0.001 per share | 7.8% | $5,182,896 | +$149,795 | 1,059,897 | +3% | Whitefort Capital Management, LP | 30 Sep 2025 |
| ABUS | Arbutus Biopharma Corp | Common Shares, without par value | 7% | $43,783,211 | 13,307,967 | Whitefort Capital Master Fund, LP | 20 Feb 2025 | ||
| BALY | Bally's Corp | Common stock, $0.01 par value (the "Shares") | 5.1% | $34,336,369 | 2,519,176 | Whitefort Capital Management, LP | 06 Mar 2026 |
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Filing Date |
|---|